ALPHA BIOLABORATORIES COVID-19 TESTING LIMITED
Executive Summary
ALPHA BIOLABORATORIES COVID-19 TESTING LIMITED exhibits strong liquidity and equity stability, indicating a healthy financial position with no immediate distress signals. However, reliance on related party transactions and a minimal capital base suggest areas for improvement to enhance financial resilience. Focused management of receivables, capital strengthening, and operational expansion are recommended to secure sustainable long-term growth.
View Full Analysis Report →- Legal registered address
- Unit 14 Webster Court Carina Park Westbrook Warrington England WA5 8WD Copied!
Latest financial results as of 13 August 2025- Current creditors
- £182.48k
- Shareholders funds
- £698.28k
View full financial accounts- Current creditors
- £182.48k
- Shareholders funds
- £698.28k
- Company number
- 12845735 Copied!
Accounts
Latest annual accounts were to 31 March 2024
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 March 2026
Confirmation statement
Latest confirmation statement statement dated 14 September 2024
Next statement due by 28 September 2025
Nature of business (SIC)
74909 - Other professional, scientific and technical activities not elsewhere classified
Latest company documents
| Date | Description |
|---|---|
| 28/03/2528 March 2025 | Total exemption full accounts made up to 2024-03-31 |
| 11/10/2411 October 2024 | Confirmation statement made on 2024-09-14 with no updates |
| 31/03/2431 March 2024 | Annual accounts for year ending 31 Mar 2024 |
| 29/12/2329 December 2023 | Total exemption full accounts made up to 2023-03-31 |
| 12/10/2312 October 2023 | Confirmation statement made on 2023-09-14 with no updates |
More Company Information
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company